Nanomaterials for enhanced immunity as an innovative paradigm in nanomedicine

Cited 21 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.authorA Seth-
dc.contributor.authorDoo-Byoung Oh-
dc.contributor.authorY T Lim-
dc.date.accessioned2017-04-19T10:03:26Z-
dc.date.available2017-04-19T10:03:26Z-
dc.date.issued2015-
dc.identifier.issn1743-5889-
dc.identifier.uri10.2217/nnm.14.200ko
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/12579-
dc.description.abstractSince the advent of nanoparticle technology, novel and versatile properties of nanomaterials have been introduced, which has constantly expanded their applications in therapeutics. Introduction of nanomaterials for immunomodulation has opened up new avenues with tremendous potential. Interesting properties of nanoparticles, such as adjuvanticity, capability to enhance cross-presentation, polyvalent presentation, siRNA delivery for silencing of immunesuppressive gene, targeting and imaging of immune cells have been known to have immense utility in vaccination and immunotherapy. A thorough understanding of the merits associated with nanomaterials is crucial for designing of modular and versatile nanovaccines, for improved immune response. With the emerging prerequisites of vaccination, nanomaterial-based immune stimulation, seems to be capable of taking the field of immunization to a next higher level.-
dc.publisherFuture Medicine Ltd-
dc.titleNanomaterials for enhanced immunity as an innovative paradigm in nanomedicine-
dc.title.alternativeNanomaterials for enhanced immunity as an innovative paradigm in nanomedicine-
dc.typeArticle-
dc.citation.titleNanomedicine-
dc.citation.number6-
dc.citation.endPage975-
dc.citation.startPage959-
dc.citation.volume10-
dc.contributor.affiliatedAuthorDoo-Byoung Oh-
dc.contributor.alternativeNameSeth-
dc.contributor.alternativeName오두병-
dc.contributor.alternativeName임용택-
dc.identifier.bibliographicCitationNanomedicine, vol. 10, no. 6, pp. 959-975-
dc.identifier.doi10.2217/nnm.14.200-
dc.subject.keywordadjuvant-
dc.subject.keywordantigen-
dc.subject.keywordantigen presenting cells-
dc.subject.keywordcross-presentation-
dc.subject.keywordimmune response-
dc.subject.keywordnanoparticle-
dc.subject.keywordvaccine-
dc.subject.localadjuvant-
dc.subject.localAdjuvants-
dc.subject.localAdjuvant-
dc.subject.localadjuvants-
dc.subject.localAntigen-
dc.subject.localAntigens-
dc.subject.localantigen-
dc.subject.localantigens-
dc.subject.localantigen presenting cell-
dc.subject.localantigen presenting cells-
dc.subject.localcross-presentation-
dc.subject.localImmune response-
dc.subject.localimmune response-
dc.subject.localNanoparticles-
dc.subject.localNanoparticle-
dc.subject.localnanoparticle-
dc.subject.localvaccine-
dc.subject.localvaccines-
dc.subject.localVaccine-
dc.description.journalClassY-
Appears in Collections:
Aging Convergence Research Center > 1. Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.